New Thinking Needed To Invigorate Japan Pharma Innovation
This article was originally published in PharmAsia News
Executive Summary
If Japan is to invigorate pharma and biotech innovation there will need to be changes to ways of thinking by both investors and research-based ventures, along with closer co-ordination between academia, industry and the government, suggested participants in a panel discussion at the BioJapan meeting in Yokohama.